These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 6883325)

  • 1. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
    Miyata H; Himeno K; Nomoto K
    Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
    Scott MT; Milas L
    Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
    Gabizon A; Leibovich SJ; Goldman R
    J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible mechanisms in the anti-tumour activity of C. parvum.
    Cullen RT
    Dev Biol Stand; 1977 Apr 13-15; 38():265-71. PubMed ID: 305375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of antitumor action of Corynebacterium parvum: replicating short-lived T cells as the mediators of potentiated tumor-specific immunity.
    Tuttle RL; North RJ
    J Reticuloendothel Soc; 1976 Sep; 20(3):209-16. PubMed ID: 1086362
    [No Abstract]   [Full Text] [Related]  

  • 7. Alterations of host resistance to Listeria monocytogenes in tumour-bearing mice and the effect of Corynebacterium parvum.
    Miyata H; Himeno K; Miake S; Nomoto K
    Immunology; 1981 Oct; 44(2):305-10. PubMed ID: 7298070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Corynebacterium granulosum on weight and histology of lymphoid organs, response to mitogens, skin allografts, and a syngeneic fibrosarcoma in mice.
    Milas L; Basic I; Kogelnik HD; Withers HR
    Cancer Res; 1975 Sep; 35(9):2365-74. PubMed ID: 807323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer.
    Masuda E; Maeda H
    Cancer Res; 1996 Apr; 56(8):1868-73. PubMed ID: 8620506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with C. parvum.
    Peters LJ; McBride WH; Mason KA; Hunter N; Basíc I; Milas L
    Dev Biol Stand; 1977 Apr 13-15; 38():297-300. PubMed ID: 608514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antitumor effect of lymphoid cells from Corynebacterium parvum-treated mice: effect of route of C. parvum administration.
    Ghaffar A; Cullen RT
    J Natl Cancer Inst; 1977 Mar; 58(3):717-20. PubMed ID: 300113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effector mechanism in concomitant immunity potentiated by intratumoral injection of Nocardia rubra cell wall skeleton.
    Ogura T; Hara H; Yokota S; Hosoe S; Kawase I; Kishimoto S; Yamamura Y
    Cancer Res; 1985 Dec; 45(12 Pt 1):6371-5. PubMed ID: 4063987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accessory cell function in tumor-bearing mice and effects of Corynebacterium parvum.
    Okuda S; Taniguchi K; Kubo C; Nomoto K
    J Natl Cancer Inst; 1982 Dec; 69(6):1293-7. PubMed ID: 6292563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumor effect of Corynebacterium parvum on C3H mouse bearing MH-134 tumor].
    Nakamura K; Miwa H; Hashimoto O; Inoue T; Orita K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1046-51. PubMed ID: 7184438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of T-cell subsets in the destruction of established metastases of 13762A rat mammary adenocarcinoma.
    Howell LE; Kreider JW; Bartlett GL
    J Natl Cancer Inst; 1986 Jul; 77(1):187-93. PubMed ID: 3487670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Corynebacterium parvum on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed.
    Fisher B; Wolmark N; Coyle J
    J Natl Cancer Inst; 1974 Dec; 53(6):1793-801. PubMed ID: 4471644
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoregulation of antitumor response; differential secretion of arachidonic acid metabolites by macrophages during stimulation in vitro with BCG and Corynebacterium parvum.
    Tomecki J; Sukiennik J; Kordowiak A
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):45-50. PubMed ID: 8239907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and in vivo homing of long-term T-cell lines and clones derived from tumor-draining lymph nodes.
    Matsumura T; Sussman JJ; Krinock RA; Chang AE; Shu S
    Cancer Res; 1994 May; 54(10):2744-50. PubMed ID: 8168105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.